Abstract:Purpose: To investigate the progression patterns and risk factors of axial elongation in young adults with non-pathologic high myopia. Design: Prospective, clinical observational cohort study with 2- to 4-year follow-up. Methods: A total of 1043 eyes of 563 participants (3515 medical records) aged 18 to 50 years with non-pathologic high myopia (axial length [AL] ≥ 26 mm; myopic maculopathy < diffuse chorioretinal atrophy; without posterior staphyloma) were included from 1546 participants (6318 medical records). Annual axial elongation was calculated via linear mixed-effect models. The associated risk factors of axial elongation were determined by ordinal logistic regression analysis, with generalized estimate equations for eliminating an interocular correlation bias. Results: Based on 5359 times of AL measurements, the annual axial elongation of participants (mean [SD] age 31.39 [9.22] years) was 0.03 mm/year (95% confidence interval [CI], 0.03-0.04, P < 0.001) during a 30.23 (6.06) months' follow-up. Severe (> 0.1 mm/year), moderate (0.05-0.09 mm/year), mild (0-0.049 mm/year), and nil (≤ 0 mm/year) elongation was observed in 122 (11.7%), 211 (20.2%), 417 (40.0%), and 293 (28.1%) eyes. The following risk factors were significantly associated with axial elongation: baseline AL≥ 28 mm (odds ratio [OR], 4.23; 95%CI, 2.95-6.06; P < 0.001); age < 40 years (OR, 1.64; 95%CI, 1.18-2.28; P = 0.003); axial asymmetry (OR, 2.04; 95%CI, 1.26-3.29; P = 0.003), and women (OR, 1.52; 95%CI, 1.13-2.2.05; P = 0.006). Using anti-glaucoma medications was a protective factor (OR, 0.46; 95%CI, 0.27-0.79; P = 0.005), which slowed 75% of axial elongation from 0.04 (0.06) to 0.01 (0.06) mm/y (P < 0.001). Conclusions: Axial elongation continued in young adults with non-pathologic myopia. Risk factors included longer baseline AL and axial asymmetry, younger age, and woman. Topical use of anti-glaucoma medications may be useful to reduce ongoing axial elongation.

A Review of Intraocular Pressure (IOP) and Axial Myopia

Towards Understanding the Aetiology of High Myopic Strabismus Using Mechanical Analysis and Finite Element Modelling

Effect of Accommodation-Induced Intraocular Pressure Changes on Myopia Onset and Development

Lowering Intraocular Pressure: A Potential Approach for Controlling High Myopia Progression

Myopic Eyeballs Morphological Structure Changes and Its Impact on Intraocular Pressure

Update on central factors in myopia development beyond intraocular mechanisms

Association Between Myopia, Biometry and Occludable Angle: the Jiangning Eye Study

Molecular changes in intraocular fluid: implications for myopia

Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia

Aqueous Humor Protein Markers in Myopia: a Review.

The Effect of Intraocular Pressure on Myopia Progression in Adolescents

How Myopia and Glaucoma Influence the Biomechanical Susceptibility of the Optic Nerve Head

Complications of high myopia: An update from clinical manifestations to underlying mechanisms

An overview of myopia genetics

Advances in biomedical study of the myopia-related signaling pathways and mechanisms

The Lack of Causal Link Between Myopia and Intraocular Pressure: Insights from Cross-Sectional Analysis and Mendelian Randomization Study

The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow

Accommodation-induced Intraocular Pressure Changes in Progressing Myopes and Emmetropes.

Myopia: Histology, clinical features, and potential implications for the etiology of axial elongation

IMI-Nonpathological Human Ocular Tissue Changes With Axial Myopia

Progression Patterns and Risk Factors of Axial Elongation in Young Adults with Non-Pathologic High Myopia: Three-year Large Longitudinal Cohort Follow-up